HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Our participation in CPHI Milan was a resounding success! With over 30 scheduled meetings at our stand, the event provided a valuable opportunity to engage productively with key players in the pharmaceutical and biotechnology industries.
Our stand perfectly reflected HTL Biotechnology’s image, creating a welcoming and professional environment that encouraged enriching discussions and new partnerships. This ideal setting facilitated fruitful and promising connections for the future of our company and its innovative projects.
Thank you to all the partners and visitors who contributed to the success of this event. We look forward to continuing these discussions and collaborating to drive innovation in our sector.
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.